# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Jul 7, 2022

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2022-07-07
- Accepted by EDGAR: Jul 7, 2022, 16:15 ET
- Period: 2022-07-05
- Accession: 0001493152-22-018802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/form8-k.htm

Filed Jul 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-018802. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
